NCT05293912 2025-03-18SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.Hangzhou Sumgen Biotech Co., Ltd.Phase 1 Terminated2 enrolled
NCT00014560 2018-05-03Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaDartmouth-Hitchcock Medical CenterPhase 1 Terminated3 enrolled 3 charts